Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-GD2 therapy

(AN-tee-… THAYR-uh-pee)
A type of treatment that helps the body’s immune system recognize and destroy cancer cells that have GD2 on their surface. GD2 is an antigen that is found in high levels on some types of cancer cells, such as neuroblastoma cells. Anti-GD2 monoclonal antibodies bind to GD2 on the cancer cells, which causes them to die. Some anti-GD2 monoclonal antibodies are being used in the treatment of neuroblastoma.
Search NCI's Dictionary of Cancer Terms